Mereo Biopharma Group Plc ADR (MREO) Stock at a key inflection point

BTIG Research raised the price target for the Mereo Biopharma Group Plc ADR (NASDAQ:MREO) stock to “a Buy”. The rating was released on October 13, 2023, according to finviz. The research report from BTIG Research has initiated the stock to Buy, with a price target set at $10. The stock was initiated by Needham, who […]